CFO
Hikal Limited
Equibles does not estimate personal net worth.
Kuldeep Jain is recorded as CFO at Hikal Limited. Kuldeep Jain has spoken on 2 earnings calls across 1 company, most recently for Hikal Limited on November 3, 2026. Hikal Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“For Q2 FY2027, our revenue reported at 434 crore, EBITDA at Rs. 25 crore, with a margin of 10.3%, and PAD at Rs. negative 6 crore. For H1 2027, our revenue stood at 837 crore, EBITDA at Rs.”
“I'm sure you must have an opportunity to go through the website and must have gone through our results. Our quarter 4-20-26 reported revenue stood at 519 crore with an EBITDA of 105 crore, and EBITDA margin is 20.3% and pat at 14.4 crore after providing an exceptional item of Rs.”
Hikal Limited
CFO
Transcript header (unverified)
Hikal Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call for the Quarter Ended September 30, 2026
Hikal Limited
Earnings Call for the Quarter Ended March 31, 2026
Hikal Limited
